Chemotherapy of Leprosy: Progress since the Orlando Congress, and Prospects for the Future

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 64, Issue 4 SUPPL., 1996, Pages

  Ji, Baohong ^a   Levy, Louis ^b   Grosset, Jacques H ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; LEPROSTATIC AGENT; MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; LEPROSY; LEPROSY CONTROL; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN;

ANIMALS; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MICE; MICE, NUDE; RECURRENCE; WORLD HEALTH ORGANIZATION;

EID: 0030444535     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CHAN, G. P., GARCIA-IGNACIO, B. Y., CHAVEZ, V.E., LIVELO, J B., JIMINEZ, C. L., PARRIKKA, M. L. P. and FRANZBLAU, S. Clinical trial of sparfloxacin for lepromatous leprosy. Antimicrob. Ag. Chemother. 38 (1994) 61-65.
2. FRANZBLAU, S., CHAN, G. P., GARCIA-IGNACIO, B. Y., CHAVEZ, V. E., LIVELO, J. B., JIMINEZ, C. L., RIKKA, M. L. P., CALVO, R. F., WILLIAMS, D. L. and GILLIS, T. P. Clinical trial of fusidic acid for lepromatous leprosy. Antimicrob. Ag. Chemother. 38 (1994) 1651-1654.
3. JAMET, P., JI, B., and THE MARCHOUX CHEMOTHERAPY STUDY GROUP. Relapse after long-term follow up of multibacillary patients treated by the W.H.O. multidrug regimen. Int. J. Lepr. 63 (1995) 195-201.
4. JI, B., JAMET, P., PERANI, E. G., Sow, S., LIENHARDT, C., PETINON, C. and GROSSET, J. H. Bactericidal activities of a single dose of clarithromycin plus minocycline, with or without ofloxacin, in patients. Submitted for publication.
5. JI, B., PERANI, E. G., PETINON, C. and GROSSET, J. H. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob. Ag. Chemother. 40 (1994) 393-399.
6. JI, B., PERANI, E. G., PETINON, C., N'DELI, L. and GROSSET, J. H. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy. Antimicrob. Ag. Chemother. 38 (1994) 662-667.
7. TrAORE, I., JI, B., LIENHARDT, C., BOBIN, P. and GROSSET, J. Determination of the minimal effective dosages of ofloxacin and sparfloxacin against Mycobacterium leprae in the mouse foot pad system. Int. J. Lepr. 64 (1996) 142-145.
8. WORLD HEALTH ORGANIZATION. Risk of relapse in leprosy. WHO document WHO/CTD/LEP/94.1.
9. WORLD HEALTH ORGANIZATION. Progress towards the elimination of leprosy as a public health problem. Weekly Epidemiol. Rec. (1995) 177-182 and 185-188.
10. WORLD HEALTH ORGANIZATION. THELEP and THEMYC Steering Committee Documents.